Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00057642 · ClinicalTrials.gov registry record · NA

Improving Retention of Hispanics Receiving Antidepressant Therapy

A NA study of Depression and Depressive Disorder, sponsored by New York State Psychiatric Institute.

Completed
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT00057642: Completed NA study of Depression and Depressive Disorder, sponsored by New York State Psychiatric Institute.

NCT00057642 is a NA study of Depression and Depressive Disorder that has completed, run by New York State Psychiatric Institute. The registered enrollment target is 50 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00057642, a NA study of Depression and Depressive Disorder, has completed, sponsored by New York State Psychiatric Institute.

COMPLETED
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

This study will develop an intervention that will increase the retention of Hispanics with major depression in antidepressant therapy.

Primary Outcome

The proportion of weeks in treatment

Interventions

  • DRUG Sertraline
  • DRUG Venlafaxine Extended Release

Study Locations (1)

New York

  • New York State Psychiatric Institute - New York

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2002-09
Est. Completion 2006-08
Phase NA

What the finished NCT00057642 record still lists

NCT00057642 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 786-participant average among 679 other Depression trials with a reported enrollment target (94% lower).

The record links to 2 conditions, with Depression appearing as the primary indexed condition, and to 2 interventions - of which Sertraline is the first listed.

NCT00057642 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT00057642 about?

NCT00057642 is a clinical study titled "Improving Retention of Hispanics Receiving Antidepressant Therapy". This study will develop an intervention that will increase the retention of Hispanics with major depression in antidepressant therapy.

What is the current status of trial NCT00057642?

This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2002-09. Estimated completion is 2006-08.

What conditions does trial NCT00057642 study?

This clinical trial studies the following conditions: Depression, Depressive Disorder.

What interventions are being tested in trial NCT00057642?

The interventions under investigation include: Sertraline (DRUG), Venlafaxine Extended Release (DRUG).

Who is sponsoring clinical trial NCT00057642?

This trial is sponsored by New York State Psychiatric Institute, which has 364 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00057642 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00057642's enrollment target sits among peer trials

50 468th of 679 higher than 199 of 679 other Depression trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00200889 · 50 participants · Early Phase 1

    Mapping Auricular Vagus Nerve Circuitry

  • NCT00409435 · 50 participants · Phase 2

    A Study of Pyridostigmine in Postural Tachycardia Syndrome

  • NCT01202305 · 50 participants

    The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies

  • NCT01225913 · 50 participants · Phase 4

    Mechanism(s) of Airflow Limitation During Exacerbation of Asthma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00057642, the US trial registry maintained by the National Library of Medicine. NCT00057642 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.